| The inoculum effect and band‐pass bacterial response to periodic antibiotic treatment C Tan, R Phillip Smith, JK Srimani, KA Riccione, S Prasada, M Kuehn, ... Molecular systems biology 8 (1), 617, 2012 | 118 | 2012 |
| Dendritic cells enhance polyfunctionality of adoptively transferred T cells that target cytomegalovirus in glioblastoma EA Reap, CM Suryadevara, KA Batich, L Sanchez-Perez, GE Archer, ... Cancer research 78 (1), 256-264, 2018 | 101 | 2018 |
| Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma CM Suryadevara, R Desai, ML Abel, KA Riccione, KA Batich, SH Shen, ... Oncoimmunology 7 (6), e1434464, 2018 | 88 | 2018 |
| Programmed Allee effect in bacteria causes a tradeoff between population spread and survival R Smith, C Tan, JK Srimani, A Pai, KA Riccione, H Song, L You Proceedings of the National Academy of Sciences 111 (5), 1969-1974, 2014 | 76 | 2014 |
| Programmed Allee effect in bacteria causes a tradeoff between population spread and survival R Smith, C Tan, JK Srimani, A Pai, KA Riccione, H Song, L You Proceedings of the National Academy of Sciences 111 (5), 1969-1974, 2014 | 76 | 2014 |
| A synthetic biology approach to understanding cellular information processing KA Riccione, RP Smith, AJ Lee, L You ACS synthetic biology 1 (9), 389-402, 2012 | 36 | 2012 |
| Generation of CAR T cells for adoptive therapy in the context of glioblastoma standard of care K Riccione, CM Suryadevara, D Snyder, X Cui, JH Sampson, ... JoVE (Journal of Visualized Experiments), e52397, 2015 | 24 | 2015 |
| Antibody-based immunotherapy for malignant glioma PC Gedeon, KA Riccione, PE Fecci, JH Sampson Seminars in oncology 41 (4), 496-510, 2014 | 18 | 2014 |
| Immunotherapy gone viral: bortezomib and oHSV enhance antitumor NK-cell activity CM Suryadevara, KA Riccione, JH Sampson Clinical Cancer Research 22 (21), 5164-5166, 2016 | 16 | 2016 |
| CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response KA Riccione, LZ He, PE Fecci, PK Norberg, CM Suryadevara, A Swartz, ... Oncoimmunology 7 (12), e1502904, 2018 | 13 | 2018 |
| A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope AM Swartz, KL Congdon, SK Nair, QJ Li, JE Herndon, CM Suryadevara, ... npj Vaccines 6 (1), 12, 2021 | 8 | 2021 |
| Checkpoint Blockade Immunotherapy for Glioblastoma: Progress and Challenges KA Riccione, P Gedeon, L Sanchez-Perez, JH Sampson Translational Immunotherapy of Brain Tumors, 261-300, 2017 | 3 | 2017 |
| IDH1 mutations as a immunotherapeutic target for brain tumors GE Archer, E Reap, P Norberg, X Cui, R Schmittling, J Herndon, ... Neuro-oncology 16 (suppl_3), iii40-iii40, 2014 | 2 | 2014 |
| Synthetic long peptide vaccines possessing a universal helper epitope can unmask the therapeutic effects of MHC I-restricted neoepitopes A Swartz, K Riccione, K Congdon, LA Sanchez-Perez, SK Nair, ... The Journal of Immunology 204 (1_Supplement), 91.26-91.26, 2020 | 1 | 2020 |
| DEVELOPMENT OF A PEPTIDE VACCINE PLATFORM FOR BRAIN TUMOR IMMUNOTHERAPY THAT INCORPORATES ADJUVANT CD27 STIMULATION FOR ENHANCED T CELL IMMUNITY K Riccione, L Riccione, JH Sampson NEURO-ONCOLOGY 18, 98-98, 2016 | 1 | 2016 |
| TMOD-14. CONJOINED CLASS I AND II EPITOPES ENHANCE NEOANTIGEN-TARGETED ACTIVE IMMUNOTHERAPY A Swartz, K Congdon, S Nair, QJ Li, J Herndon, C Suryadevara, ... Neuro-Oncology 23 (Supplement_6), vi218-vi218, 2021 | | 2021 |
| An Agonist CD27 Antibody for Brain Tumor Immunotherapy KA Riccione Duke University, 2017 | | 2017 |
| IMST-38. CAR T CELLS INDUCE COMPLETE REGRESSION OF MURINE GLIOBLASTOMA AFTER PRECONDITIONING HOSTS WITH TEMOZOLOMIDE CM Suryadevara, P Chongsathidkiet, K Riccione, PC Gedeon, R Desai, ... Neuro-Oncology 18 (suppl_6), vi94-vi95, 2016 | | 2016 |
| Immunotherapy for gliomas PE Fecci, K Riccione, GP Dunn, E Reap, G Vlahovic, K Congdon, ... The Duke Glioma Handbook: Pathology, Diagnosis, and Management, 91-120, 2016 | | 2016 |
| Characterization of a human CD27 agonistic monoclonal antibody for use as an agent in glioblastoma therapy (P4411) K Riccione, L Sanchez-Perez, C Flores, J Sampson The Journal of Immunology 190 (1_Supplement), 205.15-205.15, 2013 | | 2013 |
